1 - 14 of 14 results

NCI ALMANAC / A Large Matrix of Anti-Neoplastic Agent Combinations

Allows users to identify combinations with greater antitumor activity than either agent alone. On the NCI ALMANAC database, promising combinations could be selected for further evaluation in vitro or in human tumor xenografts models. By screening only approved drugs with proven activity and established safety profiles, combinations identified from this database offer potential for rapid translation into Investigational New Drug (IND)-exempt clinical trials.

DESMSCI / Dragon Exploration System on Marine Sponge Compounds Interactions

Provides information about Marine Sponge Compounds Interactions. DESMSCI is a public web-based knowledge base that integrates and allows exploration of information about sponge natural products and their potential biological and chemical association. The database is compiled from the published literature available in PubMed and complemented by the information from other resources. Users can explore various types of information about sponge natural products at chemical, biological and molecular levels.

DSLD / Dietary Supplement Label Database

Contains the full label contents from a sample of dietary supplement products marketed in the U.S. DSLD contains data from two sources nutrient information taken from dietary supplement labels collected from respondents in National Health and Nutrition Examination Survey (NHANES) and additional label data obtained by NHANES nutritionists. It can be used to obtain ingredients reported on the dietary supplement label and as a source of information about default data for generic dietary supplements.

AtlasCBS / Atlas of Chemico-Biological Space

Allows the exploration of these important areas of drug discovery dynamically online. AtlasCBS can be a useful resource for researchers in the drug discovery process such as: the analysis and comparison of the contents of different databases, polypharmacology, fragment-based ligand design strategies, drug discovery trajectories and others. It allows graphical visualization of database contents as pages in a map-like environment, with different variables and scales.

FDA Online Label Repository

Represents the most recent drug listing information (the drug labels and other drug-specific information) that companies have submitted to the Food and Drug Administration (FDA). FDA Online Label Repository contains drug labelling and other information which have been reformatted to make it easier to read but its content has neither been altered nor verified by FDA. The drug labelling on this web site may not be the labelling on currently distributed products or identical to the labelling that is approved. Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies described in monographs.